| Sources | Names Used |
|---|---|
| CTRPv2 | Compound 23 citrate |
| PharmacoGx | Compound 23 citrate |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ANXA5 | CTRPv2 | pan-cancer | AAC | -0.28 | 1e-09 |
| mRNA | GNG12 | CTRPv2 | pan-cancer | AAC | -0.27 | 1e-09 |
| mRNA | SYDE1 | CTRPv2 | pan-cancer | AAC | -0.26 | 1e-09 |
| mRNA | FAM127A | CTRPv2 | pan-cancer | AAC | -0.25 | 3e-09 |
| mRNA | PTRF | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-09 |
| mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-07 |
| mRNA | TFE3 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
| mRNA | PTPN14 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-07 |
| mRNA | PDZD11 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
| mRNA | EXT2 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-07 |
